Research Indicates More than 2 in 5 People Over the Age of 55 in the U.S. Will Develop Dementia
Dr. Liu discusses the development rates of dementia in the U.S. with ABC 11 Eyewitness News.
Dementia - Impact Not Just on Patients but on Families
Dr. Johnson discusses the impact of dementia on the WPTF-AM Morning News show.
Fact Check: CoQ10 Is NOT A Proven Treatment For Preventing Alzheimer's or Parkinson's Disease
Dr. Whitson discusses the misconception of CoQ10 as a treatment for Alzheimer's and Parkinson's disease.
Who's Paying for Those Blood-based Biomarker Tests for Alzheimer's Disease?
Dr. Whitson discusses the use of blood-based biomarker tests for detecting Alzheimer's and the impacts they can have on patients.
15 Warning Signs of Dementia You Shouldn’t Ignore
Dr. Whitson discusses some of the warning signs of dementia.
Lexeo Therapeutics Scores Positive Early Data for APOE4-Alzheimer’s Gene Therapy
Dr. Johnson discusses progress regarding a new gene therapy for patients that could be impacted by Alzheimer's.
Neurology Practices Create Systems for Meeting Demand for Anti-Amyloid Therapies
Kim Johnson, MD discusses the keys to a successful rollout of new treatments for Dementia and Alzheimer's.
Johnson named Duke Centennial Trailblazer
Kim G. Johnson, MD has been named a Duke Centennial Trailblazer for her work with Alzheimer's.
Finally, Some Good News About Alzheimer's
Dr. Whitson discusses advances in Alzheimer’s prevention, detection, and treatment success.
2024 Michelle Winn Awards Celebrate Achievements in Equity, Diversity, and Inclusion
Andy Liu, MD, Kim Johnson, MD, and Burt Scott, MD, PhD were recipients of this year's Michelle P. Winn Inclusive Excellence Award.